PTGX Relative Value & Intrinsic Value
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Low P/E stocks
Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
PTGX Valuation Multiples comparison vs Peer Set
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
PTGX Valuation multiples overview
PTGX Valuation multiples history vs. Peer set
Explore more intrinsic value tools hub for PTGX
FAQ
What is Protagonist Therapeutics, Inc. relative value?
As of Mar 11, 2025, Apple Relative Value is $19.9. This suggests it may be overvalued by 66.6% compared to its current price of around $59.7.
What is Protagonist Therapeutics, Inc. DCF (discounted cash flow) valuation?
As of Mar 11, 2025, Protagonist Therapeutics, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $59.7, using a discount rate of 11.1% and terminal growth rate of 3.0%.
What is Protagonist Therapeutics, Inc. intrinsic value?
As of Mar 11, 2025, Apple Intrinsic Value is $20.7. This suggests it may be overvalued by 65.3% compared to its current price of around $59.7.